Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG has been permanently discontinued (last updated September 23, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products · 1 same form & route
Affected strength40MG
Report last updated2021-09-23
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

DEPO-MEDROL

PFIZER CANADA ULC

80MG · DIN 00030767

Different strengthDifferent dosage formSame routeNo current shortage

SOLU-MEDROL

PFIZER CANADA ULC

1G · DIN 00036137

Different strengthSame dosage formSame routeNo current shortage

MEDROL

PFIZER CANADA ULC

16MG · DIN 00036129

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02231893

Strength

40MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

METHYLPREDNISOLONE

See all METHYLPREDNISOLONE products →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History